Armenia vs Oceania (exc. Australia and New Zealand): Proportion of the target population who received a 3rd dose of
Armenia
94.0%
in 2024
Oceania (exc. Australia and New Zealand)
50.0%
in 2024
Armenia rank
36th
Oceania (exc. Australia and New Zealand) rank
33rd
Proportion of the target population who received a 3rd dose of over time
- Armenia
- Oceania (exc. Australia and New Zealand)
How they compare
Armenia currently reports 94.0% against 50.0% in Oceania (exc. Australia and New Zealand), a difference of 44.0%.
That makes Armenia's figure about 1.9 times Oceania (exc. Australia and New Zealand)'s.
Across all 10 years both countries report, Armenia has been ahead every year.
Armenia ranks 36th and Oceania (exc. Australia and New Zealand) ranks 33rd of 157 countries.
Armenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Oceania (exc. Australia and New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.2% | 35.6% | 47.6% | Armenia |
| 2020s | 93.2% | 44.8% | 48.4% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Armenia or Oceania (exc. Australia and New Zealand)?
- Armenia, at 94.0% against 50.0% in Oceania (exc. Australia and New Zealand) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Armenia and Oceania (exc. Australia and New Zealand)?
- 44.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Oceania (exc. Australia and New Zealand)?
- 10 years are reported by both, from 2015 to 2024.
- How do Armenia and Oceania (exc. Australia and New Zealand) rank globally for proportion of the target population who received a 3rd dose of?
- Armenia ranks 36th and Oceania (exc. Australia and New Zealand) ranks 33rd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.